Selected Publications

El Fakiri M, Ayada N, Müller M, Hvass L, Gamzov TH, Clausen AS, Geis NM, Steinacker N, Hansson E, Lindegren S, Aneheim E, Jensen H, Eder AC, Jensen AI, Poulie CBM, Kjaer A, Eder M, Herth MM. Development and Preclinical Evaluation of [²¹¹At]PSAt-3-Ga: An Inhibitor for Targeted α-Therapy of Prostate Cancer. J Nucl Med. 2024 Apr 1;65(4):593-599. doi: 10.2967/jnumed.123.267043. PMID: 38423784.

Arbuznikova D, Eder M, Grosu AL, Meyer PT, Gratzke C, Zamboglou C, Eder AC. Towards Improving the Efficacy of PSMA-Targeting Radionuclide Therapy for Late-Stage Prostate Cancer-Combination Strategies. Curr Oncol Rep. 2023 Nov;25(11):1363-1374. doi: 10.1007/s11912-023-01458-6. Epub 2023 Oct 20. PMID: 37861915; PMCID: PMC10640479.

Hennrich U, Eder M. [¹⁷⁷Lu]Lu-PSMA-617 (Pluvicto^TM): The First FDA-Approved Radiotherapeutical for Treatment of Prostate Cancer. Pharmaceuticals (Basel). 2022 Oct 20;15(10):1292. doi: 10.3390/ph15101292. PMID: 36297404; PMCID: PMC9608311.

Hennrich U, Eder M. [⁶⁸Ga]Ga-PSMA-11: The First FDA-Approved ⁶⁸Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer. Pharmaceuticals (Basel). 2021 Jul 23;14(8):713. doi: 10.3390/ph14080713. PMID: 34451810; PMCID: PMC8401928.

El Fakiri M, Geis NM, Ayada N, Eder M, Eder AC. PSMA-Targeting Radiopharmaceuticals for Prostate Cancer Therapy: Recent Developments and Future Perspectives. Cancers (Basel). 2021 Aug 5;13(16):3967. doi: 10.3390/cancers13163967. PMID: 34439121; PMCID: PMC8393521.

Eder AC, Omrane MA, Stadlbauer S, Roscher M, Khoder WY, Gratzke C, Kopka K, Eder M, Meyer PT, Jilg CA, Ruf J. The PSMA-11-derived hybrid molecule PSMA-914 specifically identifies prostate cancer by preoperative PET/CT and intraoperative fluorescence imaging. Eur J Nucl Med Mol Imaging. 2021 Jun;48(6):2057-2058. doi: 10.1007/s00259-020-05184-0. Epub 2021 Jan 23. PMID: 33486568; PMCID: PMC8113185.

Dotter H, Boll M, Eder M, Eder AC. Library and post-translational modifications of peptide-based display systems. Biotechnol Adv. 2021 Mar-Apr;47:107699. doi: 10.1016/j.biotechadv.2021.107699. Epub 2021 Jan 26. PMID: 33513435.

Eder M, Pavan S, Bauder-Wüst U, van Rietschoten K, Baranski AC, Harrison H, Campbell S, Stace CL, Walker EH, Chen L, Bennett G, Mudd G, Schierbaum U, Leotta K, Haberkorn U, Kopka K, Teufel DP. Bicyclic Peptides as a New Modality for Imaging and Targeting of Proteins Overexpressed by Tumors. Cancer Res. 2019 Feb 15;79(4):841-852. doi: 10.1158/0008-5472.CAN-18-0238. Epub 2019 Jan 3. PMID: 30606721.